ENTRY       K09055                      KO
NAME        CEBPA
DEFINITION  CCAAT/enhancer binding protein (C/EBP), alpha
PATHWAY     ko04932  Non-alcoholic fatty liver disease (NAFLD)
            ko05200  Pathways in cancer
            ko05202  Transcriptional misregulation in cancer
            ko05221  Acute myeloid leukemia
DISEASE     H00003  Acute myeloid leukemia (AML)
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Human Diseases
              Cancers
               05200 Pathways in cancer
                K09055  CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
               05202 Transcriptional misregulation in cancers
                K09055  CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
               05221 Acute myeloid leukemia
                K09055  CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
              Endocrine and metabolic diseases
               04932 Non-alcoholic fatty liver disease (NAFLD)
                K09055  CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
            Transcription factors [BR:ko03000]
             Eukaryotic Type
              Basic leucine zipper (bZIP)
               C/EBP-like factors
                K09055  CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
GENES       HSA: 1050(CEBPA)
            PTR: 746673(CEBPA)
            PPS: 100984674(CEBPA)
            GGO: 101129792(CEBPA)
            PON: 100442871(CEBPA)
            MCC: 717153
            MCF: 102119204(CEBPA)
            MMU: 12606(Cebpa)
            RNO: 24252(Cebpa)
            HGL: 101726330 101728690
            TUP: 102477450(CEBPA)
            CFA: 100683573(CEBPA)
            AML: 100469640
            PTG: 102957285(CEBPA)
            BTA: 281677(CEBPA)
            BOM: 102264854
            PHD: 102329214
            CHX: 102177713(CEBPA)
            SSC: 397307(CEBPA)
            CFR: 102510087(CEBPA)
            BACU: 103013093(CEBPA)
            LVE: 103076258(CEBPA)
            PALE: 102893139(CEBPA)
            MDO: 100012502(CEBPA)
            SHR: 100933872(CEBPA)
            OAA: 100078506(CEBPA)
            GGA: 427549(CEBPA)
            TGU: 100224425(CEBPA)
            FAB: 101820757(CEBPA)
            PHI: 102105328(CEBPA)
            FPG: 101910670(CEBPA)
            FCH: 102046165(CEBPA)
            CLV: 102084198(CEBPA)
            AMJ: 102575011(CEBPA)
            PSS: 102448303(CEBPA)
            CMY: 102945949(CEBPA)
            XLA: 379967(cebpa) 432238
            XTR: 496454(cebpa)
            DRE: 140815(cebpa)
            TRU: 101066539 101068077
            MZE: 101474797
            OLA: 101167854
            XMA: 102236533
            LCM: 102355541(CEBPA)
            CMK: 103188072(cebpa)
REFERENCE   PMID:20422469
  AUTHORS   Reckzeh K, Cammenga J
  TITLE     Molecular mechanisms underlying deregulation of C/EBPalpha in acute myeloid leukemia.
  JOURNAL   Int J Hematol 91:557-68 (2010)
///
